美国COVID-19疫苗安全监测系统的概述
Julianne Gee1, Tom T Shimabukuro1, John R Su1
1National Center for Emerging Zoonotic Infectious Diseases, Centers for Disease Control and Prevention (CDC), Atlanta, GA, United States.
Vaccine
|April 17, 2024
概括
美国的COVID-19疫苗安全监测系统有效地追踪了不良事件,包括心肌炎,确保公共健康. 这些强大的系统确保了疫苗安全数据的及时检测,评估和透明沟通.
科学领域:
- 公共卫生 公共卫生
- 流行病学 流行病学
- 疫苗学 疫苗学 疫苗学
背景情况:
- 美国COVID-19疫苗接种计划于2020年12月开始,以缓解疾病.
- 安全监测对于疫苗计划的成功和公众信任至关重要.
- 为全面的疫苗安全监测实施了一种协调的联邦方法.
研究的目的:
- 描述美国政府的COVID-19疫苗安全监测系统.
- 用心肌炎作为案例研究来证明综合监测的有效性.
- 突出向利益相关者传达疫苗安全发现的信息.
主要方法:
- 利用既有和新的监控系统,包括被动和主动方法.
- 针对不良事件进行临床咨询,并监测特殊人群.
- 采用多个互补的系统进行信号检测,评估和验证.
主要成果:
- 成功检测,评估和验证了肌心炎后mRNACOVID-19疫苗接种的安全信号.
- 进行了长期随访,以评估心肌炎病例的康复情况.
- 证明了美国疫苗安全基础设施的响应能力和稳定性.
结论:
- 美国疫苗安全监测基础设施在国家COVID-19疫苗接种计划期间被证明是响应和强大的.
- 综合监控系统使关键安全数据的及时和透明的沟通成为可能.
- 该计划有效地预防了与COVID-19疾病相关的发病率和死亡率.
相关概念视频
Principles of Disease Surveillance
94
Disease surveillance is the systematic collection, analysis, and interpretation of health data essential to the planning, implementation, and evaluation of public health practice. This process integrates data dissemination to entities responsible for preventing and controlling disease, injury, and disability. Surveillance systems provide crucial information for action, helping public health authorities make informed decisions to manage and prevent outbreaks, ensure public safety, optimize...
94
Pharmacovigilance
830
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
830
Vaccinations
44.4K
Overview
44.4K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Clinical Trials
6.7K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.7K
Preclinical Development: Overview
4.4K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.4K


